Drug:
Reaction: ERYTHEMA
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26908282 |
80 | ||
Joint swelling, Peripheral swelling, Pustule, Balanoposthitis, Erythema, Noninfective gingivitis, |
||||
DAPAGLIFLOZIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, RAMIPRIL, FINASTERIDE, |
||||
| 302 | 26908362 |
GB |
68 | 2 |
Sneezing, Lacrimation increased, Chest pain, Swelling, Erythema, Throat tightness, |
||||
IOMEPROL INJECTION, |
||||
| 303 | 26908815 |
US |
66 | 1 |
Dermatitis atopic, Pruritus, Erythema, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 304 | 26908825 |
US |
38 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
| 305 | 26909056 |
US |
2 | |
Erythema, Injection site bruising, |
||||
OCRELIZUMAB AND HYALURONIDASE, |
||||
| 306 | 26909123 |
US |
2 | |
Eye swelling, Eye irritation, Erythema, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 307 | 26909295 |
US |
2 | |
Hepatic steatosis, Erythema, Feeling hot, Burning sensation, Pruritus, Dehydration, Furuncle, |
||||
RISANKIZUMAB-RZAA, |
||||
| 308 | 26912563 |
57 | 2 | |
Eye swelling, Ocular hyperaemia, Erythema, Periorbital swelling, Skin mass, Skin texture abnormal, |
||||
CETIRIZINE HYDROCHLORIDE, OXYGEN, 0XYGEN, ERGOCALCIFEROL, |
||||
| 309 | 26903649 |
US |
4 | 2 |
Erythema, Swelling of eyelid, |
||||
DUPILUMAB, |
||||
| 310 | 26903827 |
US |
2 | |
Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 311 | 26903828 |
US |
27 | 2 |
Eczema, Paraesthesia, Skin tightness, Erythema, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 312 | 26903878 |
US |
2 | 1 |
Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 313 | 26903918 |
US |
50 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 314 | 26904125 |
US |
34 | 2 |
Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 315 | 26904186 |
US |
90 | |
Rash, Pruritus, Feeling abnormal, Erythema, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 316 | 26904244 |
US |
12 | 1 |
Erythema, Skin swelling, |
||||
DUPILUMAB, |
||||
| 317 | 26908858 |
78 | 2 | |
Erythema, Hyperaesthesia, Burning sensation, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, LOVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, |
||||
| 318 | 26902657 |
CA |
66 | 1 |
Visual impairment, Eye infection viral, Visual impairment, Thrombosis, Eye irritation, Erythema, |
||||
RISANKIZUMAB-RZAA, |
||||
| 319 | 26902688 |
CA |
70 | |
Colitis ulcerative, Condition aggravated, Erythema, Joint swelling, Weight increased, Arthralgia, Bursitis infective, Hypertension, Infection, Skin infection, Dyspepsia, Inappropriate schedule of product administration, Intentional dose omission, Off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, PANTOPRAZOLE, |
||||
| 320 | 26902737 |
US |
73 | 2 |
Erythema, Pruritus, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 321 | 26902753 |
US |
40 | 1 |
Injection site reaction, Pruritus, Swelling, Erythema, |
||||
DUPILUMAB, |
||||
| 322 | 26902755 |
US |
53 | 2 |
Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 323 | 26902826 |
US |
28 | 2 |
Eczema, Dry skin, Pruritus, Erythema, Pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 324 | 26902846 |
US |
10 | 2 |
Mood altered, Sleep disorder due to a general medical condition, Eczema, Erythema, Skin swelling, Rash pruritic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 325 | 26903294 |
CA |
61 | 2 |
Localised infection, Pain in extremity, Erythema, Peripheral swelling, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 326 | 26903295 |
US |
1 | |
Chemotherapy, Erythema, Pruritus, Skin exfoliation, Hypersensitivity, |
||||
RISANKIZUMAB-RZAA, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 327 | 26903362 |
CA |
72 | 2 |
Secretion discharge, Back pain, Blister, Dyspnoea, Lower respiratory tract infection, Pain of skin, Chest discomfort, Erythema, Scab, Asthenia, Cough, Fatigue, Gastroenteritis viral, Neurodermatitis, Chest pain, COVID-19, Malaise, Off label use, Peripheral swelling, Skin weeping, Urticaria, Depressed mood, Gastrointestinal pain, Pruritus, Skin lesion, Dermatitis atopic, Sinusitis, Cellulitis, Chills, |
||||
DONEPEZIL HYDROCHLORIDE, DUPILUMAB, DUPILUMAB, DUPILUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIMENHYDRINATE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 328 | 26903520 |
US |
37 | 2 |
Erythema, Pruritus, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 329 | 26903595 |
KR |
||
Hepatic cirrhosis, Skin maceration, Dermatitis atopic, Skin exfoliation, Swelling face, Swelling of eyelid, Drug tolerance, Swelling, Erythema, Rash macular, Skin weeping, Vision blurred, Fatigue, Hepatitis, Therapeutic product effect decreased, Feeling hot, Cataract, Skin swelling, Rash erythematous, Folliculitis, Acne, Dermal cyst, Skin discharge, Jaundice, Erythema of eyelid, Pain, Hepatic enzyme increased, Eye movement disorder, Metabolic disorder, Pruritus, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 330 | 26903617 |
US |
76 | 1 |
Erythema, Drug ineffective, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, PHENYLEPHRINE, PHENYLEPHRINE, METHYLPREDNISOLONE, TROPICAMIDE, PREDNISOLONE ACETATE, |
||||
| 331 | 26903630 |
EU |
59 | 2 |
Rash, Erythema, Skin exfoliation, |
||||
AMOXICILLIN, |
||||
| 332 | 26897595 |
EU |
1 | |
Acute myocardial infarction, Cardiac failure, Chest pain, Dyspnoea, Blood pressure increased, Implant site haematoma, Hyperhidrosis, Hot flush, Device placement issue, Feeling hot, Heart rate increased, Palpitations, Erythema, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, ABIRATERONE ACETATE, ABIRATERONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASCORBIC ACID, MAGNESIUM OXIDE, ATENOLOL, CALCIUM CARBONATE, ANTACID, CALCIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 333 | 26897816 |
EU |
83 | 1 |
Malaise, Hypoaesthesia, Erythema, Infusion related reaction, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALFUZOSIN HYDROCHLORIDE, BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FUROSEMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 334 | 26898041 |
GB |
23 | 1 |
Chest discomfort, Dyspnoea, Eye swelling, Erythema, |
||||
INFLIXIMAB, |
||||
| 335 | 26898131 |
CO |
52 | 2 |
Finger deformity, Joint stiffness, Product dispensing issue, Therapy interrupted, Pain, Off label use, Erythema, Inflammation, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 336 | 26898372 |
BR |
62 | 1 |
Lung neoplasm, Skin lesion, Erythema, Onychoclasis, Dizziness, Hypersensitivity, Skin irritation, Paraesthesia, |
||||
PANITUMUMAB, |
||||
| 337 | 26898377 |
CA |
81 | 2 |
Conjunctival hyperaemia, Conjunctival irritation, Erythema, Vulvovaginal swelling, |
||||
| 338 | 26898446 |
US |
1 | |
Erythema, |
||||
DUPILUMAB, DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, EMPAGLIFLOZIN, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 339 | 26898514 |
CN |
81 | 2 |
Gastrointestinal haemorrhage, Urinary incontinence, Altered state of consciousness, Haematemesis, Melaena, Decreased appetite, Diarrhoea, Acidosis, Dry eye, Electrolyte imbalance, Asthenia, Hypoglycaemia, Hypotension, Pyrexia, Erythema, Inflammatory marker increased, Swelling, Dizziness, Cardiac disorder, Cold sweat, Chills, Jaundice, |
||||
DURVALUMAB, |
||||
| 340 | 26898778 |
US |
22 | 2 |
Anaphylactic reaction, Contusion, Erythema, |
||||
REMIBRUTINIB, OMALIZUMAB, |
||||
| 341 | 26898993 |
US |
77 | 2 |
Erythema, |
||||
TIRZEPATIDE, |
||||
| 342 | 26899038 |
US |
35 | 2 |
Pruritus, Erythema, Urticaria, |
||||
DUPILUMAB, |
||||
| 343 | 26899106 |
EU |
65 | 2 |
Drug hypersensitivity, Pharyngeal paraesthesia, Eye irritation, Erythema, Pruritus, |
||||
OXALIPLATIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ATROPINE SULFATE, ATROPINE, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FILGRASTIM, |
||||
| 344 | 26899170 |
US |
56 | 2 |
Headache, Flushing, Erythema, Swelling face, Pruritus, Skin burning sensation, Tachycardia, Chest pain, Emotional distress, Rash, Muscular weakness, Pain in extremity, Chest discomfort, Drug hypersensitivity, Injection site reaction, Sensitive skin, Dermatitis contact, Wound, Exposure via skin contact, Dyspnoea exertional, General physical health deterioration, Fatigue, Dizziness, Peripheral swelling, Accidental exposure to product, Product use issue, Product dose omission issue, Product quality issue, Overdose, Device leakage, |
||||
WATER, AMBRISENTAN, AMBRISENTAN, SOTATERCEPT-CSRK, |
||||
| 345 | 26899473 |
6 | ||
Psoriasis, Erythema, Off label use, Wrong technique in product usage process, |
||||
RUXOLITINIB, CLONIDINE, FAMOTIDINE, ZIPRASIDONE, ZIPRASIDONE MESYLATE, INFLIXIMAB-DYYB, POLYETHYLENE GLYCOL 3350, RISPERIDONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 346 | 26899668 |
US |
1 | |
Skin swelling, Erythema, Bloody discharge, |
||||
LARONIDASE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, HEPARIN SODIUM, LIDOCAINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ENALAPRIL MALEATE, ENALAPRIL, LORATADINE, LORATADINE ORAL, |
||||
| 347 | 26899778 |
US |
65 | 2 |
Inflammation, Rash, Erythema, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 348 | 26899872 |
BR |
2 | |
Volvulus, Coma, Immunodeficiency, Immunodeficiency, Metastases to liver, Neutropenia, Metastases to pelvis, Liver injury, Bone lesion, Weight decreased, Breast cancer, Hypoaesthesia, Metastasis, Metastases to spine, Haemorrhage, Cataract, Dark circles under eyes, Wound, Carbohydrate antigen 15-3 increased, Dry skin, Nail disorder, Red blood cell count decreased, White blood cell count decreased, Drug hypersensitivity, Rash papular, Nausea, Nausea, Eye swelling, Vulvovaginal burning sensation, Illness, Alopecia, Oral discomfort, Eyelid disorder, Haematoma, Muscular weakness, Blood disorder, Skin disorder, Tumour marker decreased, Vitamin D decreased, Malaise, Blood test abnormal, Back pain, Musculoskeletal chest pain, Cardiac disorder, Pallor, Ill-defined disorder, Skin discolouration, Administration site pain, Blood creatinine abnormal, Erythema, Asthenia, Dizziness, Anxiety, Abdominal pain, Anaemia, Fatigue, Red blood cell count decreased, Pruritus, Hypotension, White blood cell count decreased, Abdominal pain upper, Somnolence, Skin discolouration, Visual impairment, Road traffic accident, Bone erosion, Labyrinthitis, Skeletal injury, Pain, Bone pain, Blood creatinine increased, Aspartate aminotransferase increased, Alanine aminotransferase increased, Somnolence, Somnolence, Somnolence, Blood urea increased, Chest pain, Platelet count decreased, Product dose omission issue, |
||||
FULVESTRANT, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, ALPRAZOLAM, ALPRAZOLAM, LOSARTAN, AMLODIPINE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, ANASTROZOLE, ONDANSETRON HYDROCHLORIDE, |
||||
| 349 | 26900081 |
US |
73 | 1 |
Retinal degeneration, Eye swelling, Eye pain, Skin laceration, Dermatitis atopic, Pain in extremity, Rash macular, Peripheral swelling, Dry skin, Pruritus, Erythema, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 350 | 26900107 |
US |
41 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
| 351 | 26900263 |
US |
||
Abortion spontaneous, Hypersensitivity, Peripheral swelling, Erythema, Pruritus, Exposure during pregnancy, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 352 | 26900299 |
EU |
64 | 2 |
Rheumatoid arthritis, Erysipelas, Arthropod sting, Breast swelling, Erythema, Oral pain, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 353 | 26900333 |
US |
56 | 2 |
Inflammation, Drug ineffective, Erythema, |
||||
BIMEKIZUMAB, |
||||
| 354 | 26900576 |
US |
||
Swelling, Burning sensation, Erythema, |
||||
SUZETRIGINE, |
||||
| 355 | 26900834 |
US |
11 | 2 |
Dermatitis atopic, Pruritus, Erythema, Skin haemorrhage, |
||||
DUPILUMAB, |
||||
| 356 | 26900838 |
US |
2 | |
Skin irritation, Skin fissures, Erythema, Skin exfoliation, Pruritus, Dermatitis atopic, Therapeutic response decreased, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, AMOXICILLIN, SACCHAROMYCES CEREVISIAE, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, IRBESARTAN, POLYETHYLENE GLYCOL 3350, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG, DOCUSATE SODIUM, SENNOSIDES, SENNOSIDES AND DOCUSATE SODIUM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ERGOCALCIFEROL, |
||||
| 357 | 26901209 |
QA |
42 | 2 |
Angioedema, Migraine, Obesity, Pain, Sleep disorder, Pyrexia, Disturbance in attention, Fatigue, Stress, Erythema, |
||||
OMALIZUMAB, |
||||
| 358 | 26901650 |
US |
0 | 1 |
Croup infectious, Erythema, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 359 | 26901735 |
EU |
64 | 2 |
Hyperglycaemia, Asthenia, Weight decreased, Odynophagia, Erythema, Atrophic glossitis, Epstein-Barr virus infection reactivation, Pruritus, Rash maculo-papular, |
||||
INAVOLISIB, INAVOLISIB, PALBOCICLIB, FULVESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 360 | 26901760 |
EU |
33 | 2 |
Erythema, Pruritus, Swelling, |
||||
FREMANEZUMAB-VFRM, |
||||
| 361 | 26901834 |
US |
6 | 1 |
Erythema of eyelid, Pruritus, Erythema, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 362 | 26902101 |
US |
||
Erythema, Rash, |
||||
TIRZEPATIDE, |
||||
| 363 | 26902186 |
US |
37 | 2 |
Erythema, Rash, Skin burning sensation, Pruritus, Weight decreased, Abdominal pain upper, Product dose omission issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 364 | 26902267 |
CN |
48 | 1 |
Laryngeal oedema, Chest discomfort, Tachypnoea, Erythema, Swelling face, Oxygen saturation decreased, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 365 | 26902371 |
57 | 1 | |
Oedematous pancreatitis, General physical health deterioration, Palatal perforation, Feeding disorder, Weight decreased, Liver function test abnormal, Cholestasis, Erythema, Off label use, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, OXALIPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, FILGRASTIM, PANTOPRAZOLE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PEMBROLIZUMAB, |
||||
| 366 | 26892073 |
US |
34 | 1 |
Eczema, Erythema, Periorbital swelling, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 367 | 26892082 |
US |
36 | 2 |
Eye disorder, Skin swelling, Erythema, Nausea, Injection site pain, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 368 | 26892085 |
US |
69 | 2 |
Headache, Eye infection, Muscle spasms, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 369 | 26892094 |
US |
2 | |
Pruritus, Dry skin, Erythema, Skin fissures, Skin exfoliation, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, METHIMAZOLE, |
||||
| 370 | 26892168 |
CA |
77 | |
Plasma cell myeloma, Peripheral swelling, Burning sensation, Erythema, |
||||
EPTINEZUMAB-JJMR, EPTINEZUMAB-JJMR, LITHIUM, LITHIUM BROMATUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROXYUREA, |
||||
| 371 | 26892247 |
US |
49 | 2 |
Pain, Erythema, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 372 | 26892272 |
US |
1 | |
Swelling, Erythema, Injection site pain, |
||||
DUPILUMAB, ALBUTEROL SULFATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, RUXOLITINIB, |
||||
| 373 | 26892435 |
EU |
77 | 2 |
Dyspnoea, Erythema, Mouth swelling, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, RAMIPRIL, |
||||
| 374 | 26892521 |
US |
1 | |
Erythema, |
||||
GUSELKUMAB, |
||||
| 375 | 26892863 |
EU |
75 | 2 |
Anaphylactic reaction, Tachycardia, Pruritus, Nausea, Angioedema, Dyspnoea, Urticaria, Pruritus, Off label use, Erythema, Tremor, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, ACALABRUTINIB, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, |
||||
| 376 | 26893065 |
US |
34 | 2 |
Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 377 | 26893103 |
US |
50 | 2 |
Pruritus, Erythema, Rash, Skin erosion, Pain of skin, |
||||
DUPILUMAB, DUPILUMAB, AMBRISENTAN, LEBRIKIZUMAB-LBKZ, SOTATERCEPT-CSRK, TADALAFIL, |
||||
| 378 | 26893145 |
CN |
85 | 1 |
Blister, Erythema, Pruritus, Contrast media allergy, |
||||
IODIXANOL, |
||||
| 379 | 26893212 |
US |
2 | |
Erythema, Road traffic accident, |
||||
PANCRELIPASE, |
||||
| 380 | 26893235 |
CO |
66 | 2 |
Hypoxia, Erythema, Pain in extremity, Hypersensitivity, Paraesthesia, Pruritus, |
||||
IBRUTINIB, IBRUTINIB, |
||||
| 381 | 26893439 |
US |
2 | |
Dry skin, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 382 | 26893578 |
CN |
50 | 1 |
Drug eruption, Pruritus, Erythema, Skin temperature increased, Pain, Skin lesion, Blood pressure increased, |
||||
INCLISIRAN, |
||||
| 383 | 26893752 |
US |
20 | 2 |
Crohn^s disease, Lyme disease, Sunburn, Erythema, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 384 | 26893828 |
US |
3 | 2 |
Pruritus, Skin exfoliation, Erythema, Dry skin, |
||||
DUPILUMAB, |
||||
| 385 | 26894014 |
US |
22 | 2 |
Contusion, Anaphylactic reaction, Erythema, |
||||
OMALIZUMAB, REMIBRUTINIB, |
||||
| 386 | 26894019 |
US |
60 | |
Hypersensitivity, Hypoaesthesia oral, Erythema, Skin reaction, Off label use, |
||||
CYCLOBENZAPRINE HYDROCHLORIDE, MAGNESIUM, ERGOCALCIFEROL, FOLIC ACID, MONTELUKAST, METHYLPHENIDATE HYDROCHLORIDE, OLMESARTAN MEDOXOMIL, LEVOCETIRIZINE DIHYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, PANTOPRAZOLE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 387 | 26894193 |
EU |
58 | 2 |
Arthralgia, Neuropathy peripheral, Neuralgia, Swelling, Pustule, Erythema, Ageusia, Skin disorder, Abdominal discomfort, Anosmia, Pain in extremity, Hypoaesthesia, Onycholysis, Epistaxis, Swelling, Peripheral swelling, Skin hypertrophy, Nail hypertrophy, Rash, Nail disorder, Erythema, Foot deformity, Alopecia, |
||||
LEFLUNOMIDE, OXYCODONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CALCIUM CARBONATE, ANTACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 388 | 26894251 |
US |
47 | 2 |
Erythema, Pain, Muscle spasms, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 389 | 26894432 |
BR |
48 | 2 |
Blood cholesterol increased, Blood pressure increased, Nodule, Vaginal haemorrhage, Neoplasm recurrence, Bone neoplasm, Tumour inflammation, Neutropenia, Febrile neutropenia, Breast cancer metastatic, Malignant neoplasm progression, Hyperhidrosis, Madarosis, Pain, Pain, Pain, Menstrual disorder, Hair growth abnormal, Insomnia, Decreased immune responsiveness, Fatigue, Asthenia, Alopecia, Swelling, Weight increased, Hormone level abnormal, Feeling abnormal, Polymerase chain reaction positive, Iron deficiency, Sensory loss, Menstrual disorder, Menstrual disorder, Breast swelling, Nervousness, Crying, Weight decreased, Feeling hot, Skin burning sensation, Erythema, Erythema, Breast swelling, Gene mutation, Breast pain, Cardiac disorder, Blood triglycerides increased, Anaemia, Breast swelling, Application site injury, Application site oedema, Application site discolouration, Infection, Anal incontinence, Malaise, Feeling cold, Diarrhoea, Platelet count decreased, Abdominal pain upper, Abdominal pain, Abdominal pain, Pyrexia, Therapy non-responder, Headache, Headache, Vision blurred, Vision blurred, Vision blurred, Abdominal pain, Faeces soft, Blood glucose increased, Tinnitus, Mood altered, Ear pain, Dry mouth, Skin exfoliation, Pruritus, Irritability, |
||||
CIPROFLOXACIN HYDROCHLORIDE, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, GOSERELIN, DENOSUMAB, ALPELISIB, FULVESTRANT, SACCHAROMYCES CEREVISIAE, METRONIDAZOLE, |
||||
| 390 | 26894979 |
MY |
50 | 1 |
Necrotising fasciitis, IgA nephropathy, Glucocorticoid deficiency, Debridement, Cellulitis, Fall, Swelling, Erythema, Pain in extremity, Viral infection, Eczema, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 391 | 26895285 |
US |
32 | |
Erythema, Alopecia, Seborrhoea, Drug ineffective, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 392 | 26895296 |
US |
||
Dry skin, Skin exfoliation, Erythema, Off label use, Intentional overdose, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 393 | 26895405 |
US |
32 | 1 |
Acne, Erythema, Dry skin, |
||||
DUPILUMAB, |
||||
| 394 | 26895565 |
CO |
72 | 1 |
Abdominal mass, Swelling, Oedema peripheral, Erythema, Pruritus, |
||||
IBRUTINIB, LORATADINE, LORATADINE ORAL, RITUXIMAB, |
||||
| 395 | 26895576 |
US |
13 | 1 |
Tachycardia, Swelling face, Urticaria, Erythema, |
||||
IOPAMIDOL, |
||||
| 396 | 26895687 |
BR |
51 | 2 |
Pain, Insomnia, Drug interaction, Hypoaesthesia, Hyperhidrosis, Palpitations, Anxiety, Hypersensitivity, Erythema, Tinnitus, Head discomfort, Psychomotor retardation, Therapeutic response unexpected, |
||||
RAVULIZUMAB, RAVULIZUMAB, |
||||
| 397 | 26895774 |
US |
2 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 398 | 26895787 |
US |
47 | 2 |
Swelling, Hypertension, Erythema, Pruritus, Headache, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, UPADACITINIB, |
||||
| 399 | 26895870 |
US |
1 | |
Erythema, Rash, Therapy cessation, |
||||
ACETAMINOPHEN, |
||||
| 400 | 26896140 |
US |
2 | |
Dermatitis allergic, Temperature intolerance, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30